Abstract
Diabetes and hypertension are a serious public health problem worldwide. In the last decades, prevalence of these two metabolic diseases has dramatically increased in the Middle East and North Africa region, especially in Tunisia. This study aimed to determine the prevalence of type 2 diabetes (T2D) and High Blood Pressure (HBP) in Zaghouan, a North-East region of Tunisia. To this end, an exploratory study with stratified random sampling of 420 participants has been carried out. Various data were collected. Blood samples and urine were drawn for biochemical assay. Then, all data were analyzed using the statistical R software. Results showed an alarming situation with an inter-regional difference in prevalence of obesity (50.0%, CI 95.0%), HBP (39.0%, CI 95.0%) and T2D (32.0%, CI 95.0%). This study allowed the discovery of 24, 17 and 2 new cases of T2D, HBP and T2D&HBP respectively. The association of some socio-economic factors and biochemical parameters with these chronic diseases has been highlighted. To conclude, the health situation in the governorate of Zaghouan requires urgent interventions to better manage the growing epidemic of non-communicable diseases (NCD) in the region. This study demonstrated the importance of engaging health policy makers in road mapping and implementing national NCD prevention programs.
Similar content being viewed by others
Introduction
Type 2 diabetes (T2D) and High Blood Pressure (HBP) are a real burden that threaten lives considering the steep rise of their prevalence. The World Health Organization (WHO) define diabetes as a state of chronic hyperglycemia that results in fasting blood glucose (FBG) ≥ 7.0 mmol/l. This serious disease occurs when the pancreas does not produce enough insulin, or when the body becomes unable to effectively use the insulin. Insulin is a hormone that regulates the level of glucose in the blood, which is used to produce energy (https://www.who.int/news-room/fact-sheets/detail/diabetes).
Hypertension is defined when blood pressure is too high. Two numbers are used to represent blood pressure: The systolic value that represents the pressure in blood vessels when the heart contracts or beats and the diastolic value that represents the pressure in the vessels when the heart rests between beats. Hypertension is diagnosed if, when it is measured on two different days, the systolic blood pressure (SBP) readings on both days is ≥ 140 mmHg and/or the diastolic blood pressure (DBP) readings on both days is ≥ 90 mmHg (https://www.who.int/news-room/fact-sheets/detail/hypertension). In fact, these two metabolic diseases can lead to degenerative complications in eyes, blood vessels, heart and kidneys causing serious damages and deaths1,2. According to the 10th edition of International Diabetes Federation (IDF), 796,000 deaths were due to diabetes in 2021, which means one death every 5 s. Around 7.5 million deaths worldwide occur due to hypertension3. In 2021, 537 million people had diabetes3. The World Health Organization (WHO) reported that more than one billion people worldwide had hypertension4. The prevalence of these chronic diseases varies across regions and country income groups. Indeed, the Middle East and North Africa (MENA) region have the highest prevalence of hypertension and the second world’s highest rate of rise in diabetes prevalence. An epidemiological study conducted in patients from Algeria, Tunisia and Morocco showed an overall crude hypertension prevalence of 45.4%5. Hence, one of the objectives all around the world was to reduce the dramatic increase of these two multifactorial diseases. Since 2010, several public health systems have been working on reducing the prevalence of hypertension through the foundation of a doable and viable program6.
In Tunisia, the prevalence of diabetes and hypertension was at 23.0% in 20197 and 47.4% in 2018 respectively8. A projection study estimated that the prevalence of T2D in Tunisia could reach 26.6% in 20279. Most alarming, more than half of diabetic patients were undiagnosed10 and only 37.1% of people with HBP were under control. These high rates in prevalence and uncontrolled cases of diabetes and hypertension may be explained by few factors, including quick urbanization and civilization11 and insufficient screening of these diseases especially in rural areas with limited access to health care facilities. In this context, collaboration has been established between the Regional Association of Diabetics of Zaghouan, a “Tunisian Civil Society Organization (CSO)” and the Laboratory of Biomedical Genomics and Oncogenetics in Institut Pasteur de Tunis (IPT), a public health and research institution, to obtain basic data and insight on estimated prevalence of T2D and HBP in Zaghouan and identify the different clinical and environmental factors associated with both diseases. This multi-stakeholder project has put in collaboration different experts in epidemiology, statistics, and biochemistry. This study might draw the attention of health decision makers and advocates to the alarming health situation in the governorate of Zaghouan specifically and the whole country globally.
Materials and methods
Sampling method and data collection
This study was conducted in the frame of a collaboration between the “Regional Association of Diabetics of Zaghouan” and the Laboratory of Biomedical Genomics and Oncogenetics in IPT. In fact, during its raising awareness campaigns in the six districts of Zaghouan, a North-Eastern region of Tunisia, the CSO has noted high prevalence of T2D and HBP in the region. Taking this observation into account, a study of the prevalence of T2D and HBP in the governorate of Zaghouan as well as the determination of associated risk factors was proposed. Hence, an exploratory study has been conducted to investigate the health situation in the region of Zaghouan.
The study population were recruited using a stratified random sampling method12. The sample size was determined based on the size of the Zaghouan population (inhabitants’ number) that hosts 160,963 residents in 201813. We used Cochran’s formula to set the size of the representative sample with a margin of error of 5.0% as the following14.
-
1.96: sampling confidence interval, for CI 95.0%
-
0.5: expected proportion (p) of a population response or actual proportion. By default, it is set to 0.5, which allows for the largest possible sample
-
0.05: margin of sampling error, 5.0%
Thus, according to the formula, the sample size was around 384 Zaghouan adults. In practice, we increased the sample size to 420 volunteer participants from the six districts of Zaghouan distributed as mentioned in Table 1. The sample size was increased by 10.0% to ensure the required number of correct responses and measurement error.
We included in the study all aboriginal inhabitants of the Zaghouan region aged of 30 years old or above whatever their health status (T2D/No T2D and/or HBP/No HBP). Excluded from the study were all non-inhabitants of the Zaghouan region and all participants with T1D. This study was driven during 2 months from June to August of 2020.
Ethics approval
The study was conducted according to the declaration of Helsinki and was approved by the Ethical Committee of the Institut Pasteur de Tunis (Registration number IRB00005445, FWA00010074, ref .2019/14/I/LR16IPT/V4).
Methods and variables of measurements
In the present study, many variables and measurements were studied such as demographic (gender, age, marital status), anthropometric (Body Mass Index (BMI), Waist circumference (WC)), clinical (medical history, diabetes history, Blood Pressure (BP), treatment), genealogical, socio-economic data, data related to life-style and biological variables (biochemical measures). Diabetes was defined as Fasting Plasma Glucose (FPG) ≥ 1.26 g/l (7.00 mmol/l) or HbA1C ≥ 6.5% in accordance to the American Diabetes Association (ADA) recommendations15. HbA1C was performed in the biochemistry laboratory in IPT using certified and standardized method. Screening for prediabetes and risk for future diabetes was based on the value of HbA1c (%). In this study, were considered as prediabetic, participants who were not previously diagnosed as diabetic with HbA1c ranges between 5.7 and 6.49%15. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg and diastolic blood pressure (DBP) ≥ 90 mmHg at the time of the study16. Indeed, for participants who had high blood pressure at the moment of the recruitment and known as not hypertensive, they will be referred to a health clinic unit to measure their blood pressure for 1 week in order to confirm the diagnosis of HBP. In this study, were considered as pre-hypertensive, participants who had a SBP in the range of 120–139 mmHg and a DBP between 80 and 89 mmHg at the time of the study and known as not hypertensive subjects. Overweight and obesity were defined as BMI ranges of 25–29.9 kg/m2 and ≥ 30 kg/m2 respectively17. In this study abdominal overweight was defined as Waist Circumference (WC) ranged between 95 to 102 cm for men and from 81 to 88 cm for women. Abdominal obesity was considered present in men and women if WC was ≥ 102 and WC ≥ 88 cm18 respectively. WC was measured across the belly button wearing light clothing by trained staff using a measuring tape on the subject while they were standing and breathing normally.
A signed informed consent was obtained from the 420 participants recruited during the raising awareness campaigns organized by the CSO’s volunteers, who have been trained on good practice in data collection and participants recruitment, in the six districts of Zaghouan. Then, clinical examination and questionnaire were used to collect demographic (e.g., age, gender, place of residence in Zaghouan), anthropometric (e.g., height, weight), clinical (e.g.: blood pressure (BP), capillary blood glucose), genealogical, and socio-economic data (e.g. educational level, socio-professional category), as well as data related to life-style (physical activity, smoking, alcohol consumption and stress). Blood samples and urine were also collected from each participant. Finally, all samples were pseudonymised and centralized at the regional hospital of Zaghouan for biochemical analyses. Some biochemical analyses were performed in the biochemistry laboratory of in IPT. The biochemical parameters measured were: Fasting Plasma Glucose (FPG), Glycated Hemoglobin (HbA1c), Total Cholesterol (T-CHL), LDL-c (Low Density Lipoprotein), Triglycerides (TG), Albuminuria (Alb), High Sensitivity C Reactive Protein (CRP), urea, 25-hydroxy vitamin D (25-OH Vit D) and Creatinine. All clinical and biological data were centralized in a codified and secure database for statistical analyses.
Statistical analyses
All collected data were integrated into a secure database for statistical analysis using the data mining R software for Windows version 4.0.219. To describe the demographic and clinical characteristics of the population, means and frequencies (in percentages) for people with and without T2D and HBP were reported. Our population study was stratified into six groups according to the HbA1C level and the BP. A multivariate logistic regression analyses was conducted between two groups (NoT2D No HBP Vs T2D&HBP) to identify variables associated with both conditions. Statistical significance was set at P < 0.05. Comparison between groups was performed using Student t-test and chi2-test.
Results
There were 420 eligible subjects who participated in this study. Table 2 describes all collected data: age distribution, BMI, WC and biochemical measurements among the study population. The mean age of participants was about 57.22 ± 13.52 years. Among these participants, 76.0% (n = 318) were female and 24.0% (n = 102) were male. The mean BMI of the study population was elevated in the range of 30.06 ± 5.88 kg/m2.
A proportion of 44.5% of men (n = 45) and most women of the study, 85.0% (n = 271) had abdominal obesity. Biochemical measures, diabetes and hypertension status for men and women with abdominal overweight and obesity are mentioned in Table 3.
Biochemical analyses allowed the discovery of 24, 17 and 2 new cases of T2D, HBP and T2D&HBP respectively. Indeed, at the time of the recruitment, some volunteers were unaware about their diabetes and/or arterial hypertension and were classified as non-diabetics and/or non-hypertensives participants. Taking into consideration the number of known and newly identified cases, we calculated the prevalence of T2D and HBP in the Zaghouan region. Altogether, the study population was composed of 16.0% of diabetes, 23.0% of hypertension, 16.0% of diabetes and hypertension and only 45.0% of the population had neither diabetes nor hypertension (Fig. 1).
The overall prevalence of obesity, HBP and T2D among Zaghouan population were at 50.0% (CI 95.0%), 39.0% (CI 95.0%) and32.0% (CI 95.0%) respectively. Diabetes and hypertension proportions were statistically different between Zaghouan districts. We noted that the district of BirMchergua was the most affected by diabetes (31.3%) and hypertension (44.7%) (Fig. 2).
In this study, we determined the status distribution of T2D and HBP among overweight (Fig. 3A) and obese (Fig. 3B) groups. Results showed that both diabetes and hypertension were present in 37.0% of the obese group regarding only 17.0% among overweight group.
Regarding diabetes and hypertension complications, more than 60.0% of the diabetic and hypertensive groups of our study population had macro and microvascular complications. About 40.0% of these patients had concomitant dyslipidemia. Our analysis showed that the occurrence of complications was often more than doubled among diabetic and hypertensive patients with concomitant condition such as obesity. Indeed, among diabetic and hypertensive patients with obesity, more than 45.0% had both macro and microvascular complications. Our examination showed that only 9.0% of participants were healthy, non-diabetic, non-hypertensive and non-obese without complications. To sum up, we established an epidemiological map of the Zaghouan region showing the clinical heterogeneity of Zaghouan population regarding chronic diseases (Fig. 4).
Factors associated with T2D and HBP
The bivariate and multivariate logistic regression analysis conducted between groups with and without diabetes and hypertension showed a significant association of age, BMI, WC, academic level and socio-professional categories with T2D and HBP. Regarding variables related to life-style, there was a strong association between physical activity (OR 5.64, p-value < 0.01), Smoking (OR 4.00, p-value < 0.05), alcoholism (OR 3.00, p-value < 0.05) and both diseases. For biochemical measures; albuminuria, creatinine and urea showed a statistically significant association with T2D and HBP. Our analysis showed no significant link between 25-OH Vit D and both diseases (Table 4).
Discussion
This study sought to determine the prevalence of T2D and HBP in the governorate of Zaghouan in Tunisia (North East province) as well as their associated risk factors. As far as we know, this was the first study in the Zaghouan region that allowed to have important data and insight on the epidemiology of T2D and HBP in this region. Our findings showed that T2D prevalence in Zaghouan region is higher than that determined in the Governorate of Nabeul (P = 7.2%) (North Eastern) in 200220. In the neighboring region, we found Algeria that has conducted similar studies to determine the prevalence of diabetes or hypertension at the regional level, such as the areas of Tlemcen21 and Blida22 in Northern Algeria and the El-Menia oasis in central Algeria Sahara23. Several studies of this type have also been carried out in the Middle East, including those by Al Khatam Nazih et al. in Dammam and Qatif24 in the Eastern province of Saudi Arabia and in Ahvaz in the Southwest of Iran25.
Our exploratory study highlighted a high prevalence of diabetes (32.0%, CI 95.0%) and hypertension (39.0%, CI 95.0%) among Zaghouan adults aged of 57.22 ± 13.52 years. Prevalence distribution was statistically different across Zaghouan districts where BirMchergua had the highest prevalence of both T2D (31.3%) and HBP (44.7%). In fact, the high rates of diabetes and hypertension in the district of BirMchergua compared to other Zaghouan’s district may be explained by cultural traditions, socio-economic indicators and environmental factors including water and climate. According to the literature, the district of BirMchergua has a low socio-economic level with a poverty rate of 17.0% and 19.8% unemployment. Also, poor access to health care facilities was noted in the Bir Mchergua area, with only one basic health care center available in the region26. The Table 5 summarized the number of hospitals in the six districts of Zaghouan. In addition, the high salinity of the drinking water in the region of BirMchergua27 may affects the endocrine system of inhabitants and leads to the development of diabetes and hypertension via sodium-retention mechanism28,29.
The prevalence of diabetes in Zaghouan (32.0%; CI 95.0%) is higher than that reported in entire Tunisia (23.0%). Indeed, in a previous study, the prevalence of diabetes was calculated on a representative sample of the entire Tunisian population from the 24 districts of Tunisia7. However, in the present study we included only inhabitants of Zaghouan. The difference in the prevalence may be also explained by the number and the access to health care facilities which is easier in some Tunisian districts such as Tunis (the capital), than in Zaghouan region. For example, 22 hospitals are available in the district of Tunis Vs only 2 hospitals in the Zaghouan region. Compared to neighboring countries such as Algeria, Morocco and Libya, epidemiological situation seems to be the same as observed in Tunisia from 2000 to 20197. This similarity at epidemiological level can be explained by the fact that the Maghreb region shares the same lifestyle and eating habits30. Looking at the entire North Africa region, Egypt had the highest prevalence of T2D in 2019. Nevertheless, no data on the prevalence of diabetes in other north African countries have been recorded such as Mauritania31. On the other hand the situation of HBP in the Zaghouan region is alarming (P = 39.0%, CI 95.0%) as observed in the whole Tunisia (P = 47.4%, CI 95.0%)8.
Our investigation revealed that overweight (30.0%) and obesity (50.0%) were the most emergent public health problems facing the governorate of Zaghouan. This observation is confirmed by epidemiological studies showing a rapid increase in obesity among Tunisian population; it went from 12.2% (6.1% in men, 18.3% in women, p < 0.001) in 200132 to 27.1% in 201633. Our results showed that overweight and obesity were higher among Zaghouan women than Zaghouan men. This observation is in accordance with previous studies highlighting the gender-obesity relationship due to gender differences in cultural (regional) habits34,35.
In addition, our study showed that abdominal obesity was also a serious public health condition in the region especially among women (85.0%) and even among men (44.5%). Furthermore, 23.7% and 35.4% of women with diabetes and hypertension respectively had abdominal overweight and obesity. Similarly, 35.3% and 25.0% of men with diabetes and hypertension respectively had abdominal overweight and obesity. Added to that, diabetes and hypertension were present twice as many among the obese group (47.0%) than the overweight one (15.0%). All these results confirm well that obesity is a major risk factor for diabetes and HBP18,36.
Moreover, it is interesting to mention that 6.0% of diabetics and 5.0% of hypertensives people were newly discovered after biological analyses. In the same way, Ben Romdhane et al. have identified 7.7% new cases of T2D during a national health examination in Tunisia10. This survey showed that 3.0% and 13.0% of Zaghouan adults were respectively pre-hypertensive and pre-diabetic, which will increase the prevalence of these two diseases in Zaghouan population in the next few years.
For cardiovascular complications, results showed that more than 60.0% of diabetic and hypertensive participants had macro and microvascular complications. Indeed, 45.0% of Zaghouan population suffered from dyslipidemia leading to serious complications, including cardiovascular damages37. At physiological level, dyslipidemia associated to diabetes promoted toxic changes (oxidation, glycosylation) and increases significantly the risk of cardiovascular diseases38. These results are consistent with previous Tunisian studies highlighting high cardiovascular risk among diabetic, obese, and hypertensive patients39.
Regarding associated risk factors, our analysis showed a significant association of age, socio-professional categories and academic level with both diabetes and hypertension. These findings are in agreement with the results of the Tunisian Health examination survey40. However, early epidemiological Tunisian studies conducted on a random sample from all over Tunisia, showed that employment or education level did not appear to affect the prevalence of T2D10. This discrepancy may suggest that geographic regions can play an important role in the spread of diabetes and its risk factors. Moreover, our logistic regression analysis revealed a significant association of alcoholism, smoking and physical activity with T2D and HBP. In particular, the strongest association was found between both diseases and physical activity (OR 5.64, p-value < 0.01). Nevertheless, Ryan et al. demonstrated that heavy smoking has the strongest association with the risk to develop chronic diseases11. For biochemical parameters, our investigation revealed an association between Micro Alb, Creatinine, Urea and both diseases. In this context, Liu et al. showed that TG, and T-CHL were some of the main factors associated to T2D41. Our results revealed no significant link between 25-OH Vit D (OR 1.04, p-value = 0.2) and both diseases. This finding is in accordance with a genome wide association study proving the absence of any significant association between variants among Vitamin D related genes neither its metabolites and T2D42. Concerning the role of Vitamin D in blood pressure regulation, Grundmann et al. disconfirm any positive correlation43. While, meta-analysis studies have shown an inverse relationship between 25-OH Vit D levels and T2D44 as well as blood pressure45 and justify the use of Vitamin D supplementation for the prevention of T2D46 and HBP47. Disagreement regarding association between 25-OH Vit D and risk for chronic diseases is exiting and can be explained by heterogeneity among different populations, the study design and sample size.
Furthermore, our results showed a Vitamin D deficiency among Zaghouan population and especially among individuals aged over 70 years old. These results fits with what was reported by Fakhfakh et al. that prevalence of Vitamin D deficiency is common in Tunisia48.
Our results could be of great help for health care providers to reduce the incidence of these metabolic diseases and related complications. It seems that the lack of awareness and the limited health education of Zaghouan population is the main cause of rise in diabetes and hypertension prevalence. Therefore, we suggest (i) to promote more education about diabetes, hypertension and obesity, (ii) to develop wide screening for general population and reduce some controllable risk factors such as alcoholism and smoking, (iii) to encourage people to do physical exercises49 and (iv) to improve the management of patients with diabetes and hypertension including co-morbidities such as cardiovascular complications50. Given its great socio-economic impact, this study could be Conducted at a larger scale in all regions of Tunisia in order to determine the overall prevalence of diabetes and hypertension.
We noticed that the short period of the study cannot support conclusions on the risk of disease, nor on causal relationships and may be considered as a limitation of our study.
To the best of our knowledge, this study is the first of its kind determining the epidemiological situation of chronic diseases among the northern East Tunisian population. It provides data regarding the prevalence of diabetes, hypertension and obesity as well as their associated risk factors. Thanks to this study, we were able to identify new cases of diabetes and hypertension. Also, screening for prediabetic and pre-hypertensive individuals provides new insights towards non-communicable disease prevention. In fact, our results would help to establish a National Program of NCD Prevention adapted to the specificities of the Tunisian population. Taking note, these findings will give valuable information to health policy-makers in the implementation of hygienic and dietary measures.
The originality of this study lies in the heterogeneous genetic landscape of the studied population and the involvement of the CSO. Involving local communities might help decelerate the growing menace of diabetes and hypertension in the country. In addition, involving all the actors and stakeholders i.e. local decision makers, health professionals and citizens on road mapping and public health design will help to bridge the know-do-gap in public health innovation and scientific knowledge sharing. The systematic collaboration of different partners in different sectors allows us to continue networking as an element of sustainability after the end of the project.
Conclusion
The present exploratory study showed a high prevalence of obesity, hypertension and diabetes in the governorate of Zaghouan and point up the high prevalence of undiagnosed people. We highlighted also an inter-regional difference in terms of T2D and HBP prevalence as well as the associated risk factors like socio-economic features and biochemical parameters with the development of these chronic diseases. We showed that physical activity was the main associated risk factor in the development of T2D and HBP in this region. In perspective, it would be interesting to complete this study with genetic and microbiota investigations in order to better understand the relationship between the two diseases and the gene-environment interaction.
Data availability
All data generated or analyzed during this study are included in this published article. For any request regarding the data published in the present paper, please contact the corresponding author Pr. Rym KEFI (rym.kefi@pasteur.utm.tn; rym.kefi@pasteur.tn).
References
Avogaro, A. & Fadini, G. P. Microvascular complications in diabetes: A growing concern for cardiologists. Int. J. Cardiol. 291, 29–35 (2019).
Zanchetti, A. Epidemiological, pathophysiological and therapeutic aspects of hypertension. J. Hypertens. 35, 1917–1918 (2017).
Cho, N., Kirigia, J., Ogurstova, K. & Reja, A. IDF Diabetes Atlas (2021).
Tabrizi, J. S., Sadeghi-Bazargani, H., Farahbakhsh, M., Nikniaz, L. & Nikniaz, Z. Prevalence and associated factors of prehypertension and hypertension in Iranian population: The lifestyle promotion project (LPP). PLoS ONE 11, 1–15 (2016).
Nejjari, C. et al. Epidemiological trial of hypertension in North Africa (ETHNA): An international multicentre study in Algeria, Morocco and Tunisia. J. Hypertens. 31, 49–62 (2013).
Dzudie, A. et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Cardiovasc. J. Afr. 28, 262–273 (2017).
Prevalence of Diabetes in the Tunisian Population: Results of the ATERA-Survey. https://www.sciencedirect.com/science/article/abs/pii/S1878648022005341.
Boujnah, R., Nazek, L., Maalej, M., EL Achhab, Y. & Nejjari, C. Hypertension in Tunisian adults attending primary care physicians (ETHNA-Tunisia). Indian Heart J. 70, 544–547 (2018).
Saidi, O. et al. Forecasting Tunisian type 2 diabetes prevalence to 2027: Validation of a simple model Biostatistics and methods. BMC Public Health 15, 1–8 (2015).
Ben Romdhane, H. et al. Prevalence of diabetes in Northern African countries: The case of Tunisia. BMC Public Health 14, 1–13 (2014).
Ng, R., Sutradhar, R., Yao, Z., Wodchis, W. P. & Rosella, L. C. Smoking, drinking, diet and physical activity—Modifiable lifestyle risk factors and their associations with age to first chronic disease. Int. J. Epidemiol. 49, 113–130 (2020).
Taherdoost, H. Sampling methods in research methodology: How to choose a sampling technique for research. SSRN Electron. J. 5, 18–27 (2018).
Ministère de la santé. Santé Tunisie en chiffres 2018 (2018).
Cochran, W. Sampling Techniques 3rd edn, Vol. 3 (Wiley, 1977).
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care 44, S15–S33 (2021).
James, P. A. et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J. Am. Med. Assoc. 311, 507–520 (2014).
Nuttall, F. Q. Body mass index: Obesity, BMI, and health: A critical review. Nutr. Today 50, 117–128 (2015).
Jacobsen, B. K. & Aars, N. A. Changes in waist circumference and the prevalence of abdominal obesity during 1994–2008—Cross-sectional and longitudinal results from two surveys: The Tromsø study. BMC Obes. 3, 1–8 (2016).
R Core Team. R A Language and Environment for Statistical Computing. https://scirp.org/reference/referencespapers.aspx?referenceid=3064798 (R Foundation for Statistical Computing, Scientific Research Publishing, 2020).
Gharbi, M., Akrout, M. & Zouari, B. Prevalence and risk factors of non-insulin-dependent diabetes mellitus in the rural and urban population of Tunisia. Rev. Epidemiol. Sante Publ. 50, 349 (2002).
Zaoui, S., Biémont, C. & Meguenni, K. Epidemiology of diabetes in urban and rural regions of Tlemcen (Western Algeria). Cah. Sante 17, 15–21 (2007).
Bachir Cherif, A. et al. Prevalence of diabetes and dyslipidemia in hypertensive patients in the area of Blida (Algeria). Ann. Cardiol. Angeiol. 67, 198–203 (2018).
Hamida, F. et al. Prévalence de l’hypertension artérielle dans l’oasis d’El-Menia, Algérie, et profil métabolique de la population. Ann. Cardiol. Angeiol. (Paris) 62, 172–178 (2013).
Kim, J. H. et al. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol. 16(14), 1782–1787. https://doi.org/10.3748/wjg.v16.i14.1782 (2010).
Yazdanpanah, L. et al. Prevalence, awareness and risk factors of diabetes in Ahvaz (South West of Iran). Diabetes Metab. Syndr. Clin. Res. Rev. 10, S114–S118 (2016).
MDiCI. Élaboration d’un plan de développement stratégique du gouvernorat de Zaghouan a l’Horizon 2030 Troisième phase : Rapport de Synthèse et moyen de mise en oeuvre Commissariat Général au Développement Régional Groupement Troisième phase: Rapport de synthèse 1–183 (2017).
Hamed Ferjani, A., Guellala, R., Amiri, A., Merzougui, A. & Inoubli, M. H. Structuration profonde dans la région de Bir M’Chergua (Nord-Est de la Tunisie). Implications hydrogéologiques. Estud. Geol. 74, 075 (2018).
Sondermann, M. et al. Diabetes mellitus and hypertension—A case of sugar and salt? Int. J. Mol. Sci. 21, 1–7 (2020).
Yatabe, M. S. et al. Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am. J. Clin. Nutr. 92, 77–82 (2010).
Mutyambizi, C., Booysen, F., Stokes, A., Pavlova, M. & Groot, W. Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: A decomposition analysis. PLoS ONE 14, 1–21 (2019).
Diabetes, W. J. Contents, Vol. 9358 (2021).
Prevalence of Obesity and Overweight in Tunisia on 2001. https://pubmed.ncbi.nlm.nih.gov/19472725/.
Tunisia. 2016 (2016).
Mokhtar, N. et al. Symposium: Obesity in Developing Countries: Biological and Ecological Factors Diet Culture and Obesity in Northern Africa 1 887–892 (2018).
Lemamsha, H., Randhawa, G. & Papadopoulos, C. Prevalence of overweight and obesity among Libyan men and women. Biomed. Res. Int. 2019, 1–16 (2019).
Al-Sumaih, I., Johnston, B., Donnelly, M. & O’Neill, C. The relationship between obesity, diabetes, hypertension and vitamin D deficiency among Saudi Arabians aged 15 and over: Results from the Saudi health interview survey. BMC Endocr. Disord. 20, 1–9 (2020).
Masilela, C., Pearce, B., Ongole, J. J., Adeniyi, O. V. & Benjeddou, M. Cross-sectional study of prevalence and determinants of uncontrolled hypertension among South African adult residents of Mkhondo municipality. BMC Public Health 20, 1–11 (2020).
Drexel, H. et al. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 28, 101–107 (2005).
Jemaa, R., Razgallah, R., Ben Ghorbel, I., Rais, L. & Kallel, A. Prevalence of cardiovascular risk factors in the Tunisian population: The ATERA-survey. Arch. Cardiovasc. Dis. Suppl. 12, 159 (2020).
Tunisian Health Examination (2019).
Liu, S. et al. Application of three statistical models for predicting the risk of diabetes. BMC Endocr. Disord. 19, 1–10 (2019).
Zheng, J. S. et al. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis. PLoS Med. 17, 1–21 (2020).
Grundmann, S. M. et al. Vitamin d receptor deficiency does not affect blood pressure and heart function. Front. Physiol. 10, 1–11 (2019).
Lips, P. et al. Vitamin D and type 2 diabetes. J. Steroid Biochem. Mol. Biol. 173, 280–285 (2017).
Nwosu, B. U. & Maranda, L. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus. PLoS ONE 9, 1–9 (2014).
Von Hurst, P. R., Stonehouse, W. & Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br. J. Nutr. 103, 549–555 (2010).
Wuerzner, G., Burnier, M. & Waeber, B. Hypertension et vitamine D: Retour sur la scène. Rev. Med. Suisse 7, 121–124 (2011).
Fakhfakh, R. et al. Vitamin D status and CYP27B1-1260 promoter polymorphism in Tunisian patients with systemic lupus erythematosus. Mol. Genet. Genom. Med. 9, 1–9 (2021).
Leiva, M., Cristi-Montero, S., Ramírez-Campillo, D., Aguilar-Farías, C.-M. & Leiva, M. El sedentarismo se asocia a un incremento de factores de riesgo cardiovascular y metabólicos independiente de los niveles de actividad física 458–467 (2014).
Mc Namara, K., Alzubaidi, H. & Jackson, J. K. Cardiovascular disease as a leading cause of death: How are pharmacists getting involved? Integr. Pharm. Res. Pract. 8, 1–11 (2019).
Acknowledgements
First, the authors would like to thank the study participants for their collaboration. They would like to express our gratitude to all team members of the Regional Association of Diabetics of Zaghouan for the enormous amount of fieldwork in collecting clinical and biological data from all participants during awareness campaigns mainly Khira HAFFANI, Ilhem FESSI, Mabrouka JABRI, Dalel TAKOUTI, Souad CHRAITI, Nawel HASSAN, Nada LAABIDI, Hanen RHIMI, Najiba HASSINI, Mariem HICHRI, Sonia GUITOUNI and Houda HNIA. They address special thanks to Mrs. Amel BELLAFI, the head of the regional office commissariat for Women, Family and Elderly people of Zaghouan. They address many thanks to Sandeep Kaur-Ghumaan for the English revision.
Funding
Horizon 2020 funded this study under grant agreement No 741677 in the frame of “la Boutique des Sciences de l’Institut Pasteur de Tunis”, “Science Ensemble-العلم مع بعضنا” for InSPIRES project “Ingenious Science shops to promote Participatory Innovation, Research and Equity in Science”. This work was supported by the Tunisian Ministry of Public Health (Personal costs) and the Ministry of Higher Education and Scientific Research (LR16 IPT05). N.K. is a recipient of a MOBIDOC fellowship, funded by The Ministry of Higher Education and Scientific Research through the PromEssE project and managed by the ANPR. This funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Conceptualization: N.K., R.K., T.D., S.M., H.B.H. Data curation: N.K., T.D., M.T.T. Formal analysis: N.K., H.T., M.S. Funding acquisition: R.K., H.B.H. Methodology: N.K., R.K., T.M., M.M., W.K.R., M.K., A.B. and A.A. Project administration: S.M. and H.B.H. Writing—original draft: N.K. Writing—review & editing: N.K., R.K., F.M., H.J., S.A. All authors contributed to the manuscript revision and approved the submitted version. All participants gave their free informed consent and data was analyzed anonymously.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kheriji, N., Dakhlaoui, T., Kamoun Rebai, W. et al. Prevalence and risk factors of diabetes mellitus and hypertension in North East Tunisia calling for efficient and effective actions. Sci Rep 13, 12706 (2023). https://doi.org/10.1038/s41598-023-39197-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-39197-0
- Springer Nature Limited